Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MYO-SLD : a Prospective Study to Determine the Phenotype of Muscle Fat Accumulation in a Cohort of Patients With SLD as to Confirm the Association Between Muscle Composition and Texture and the Phenotype of Liver Disease

NCT06514300 is registered in ClinicalTrials.gov with Cliniques universitaires Saint-Luc- Université Catholique de Louvain as lead sponsor.

NCT NCT06514300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06514300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MYO-SLD : a Prospective Study to Determine the Phenotype of Muscle Fat Accumulation in a Cohort of Patients With SLD as to Confirm the Association Between Muscle Composition and Texture and the Phenotype of Liver Disease
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase
Observational
Overall status
Unknown status
Start date
June 22, 2020
Completion date
August 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol-related liver disease, liver histology, magnetic resonance imaging, magnetic resonance spectroscopy, metabolic dysfunction associated steatotic liver disease, myosteatosis, steatotic liver disease of mixed origin (metald), steatotic liver diseases